Maria Grazia Bernengo, Pietro Quaglino, Alessandra Comessatti, Michela Ortoncelli, Mauro Novelli, Francesco Lisa, and Maria Teresa Fierro. 2007. “Low-Dose Intermittent Alemtuzumab in the Treatment of Sézary Syndrome: Clinical and Immunologic Findings in 14 Patients”. Haematologica 92 (6). Pavia, Italy, 784-94. https://doi.org/10.3324/haematol.11127.